Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares Issued
Ratios

OptimizeRx (OPRX) Receivables - Net (2016 - 2025)

OptimizeRx (OPRX) has disclosed Receivables - Net for 16 consecutive years, with $37.8 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net fell 1.2% to $37.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.8 million through Dec 2025, down 1.2% year-over-year, with the annual reading at $37.8 million for FY2025, 1.2% down from the prior year.
  • Receivables - Net hit $37.8 million in Q4 2025 for OptimizeRx, up from $32.2 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $38.2 million in Q4 2024 to a low of $757218.0 in Q3 2021.
  • Historically, Receivables - Net has averaged $18.9 million across 5 years, with a median of $18.2 million in 2023.
  • Biggest five-year swings in Receivables - Net: tumbled 94.32% in 2021 and later skyrocketed 710.64% in 2025.
  • Year by year, Receivables - Net stood at $24.8 million in 2021, then decreased by 10.67% to $22.2 million in 2022, then surged by 63.63% to $36.3 million in 2023, then increased by 5.4% to $38.2 million in 2024, then decreased by 1.2% to $37.8 million in 2025.
  • Business Quant data shows Receivables - Net for OPRX at $37.8 million in Q4 2025, $32.2 million in Q3 2025, and $33.5 million in Q2 2025.